63 related articles for article (PubMed ID: 16750627)
1. Synthesis and biological evaluation of type VI beta-turn templated RGD peptidomimetics.
Creighton CJ; Du Y; Santulli RJ; Tounge BA; Reitz AB
Bioorg Med Chem Lett; 2006 Aug; 16(15):3971-4. PubMed ID: 16750627
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of thioether building blocks into an alphavbeta3-specific RGD peptide: synthesis and biological activity.
Kelleman A; Mattern RH; Pierschbacher MD; Goodman M
Biopolymers; 2003; 71(6):686-95. PubMed ID: 14991678
[TBL] [Abstract][Full Text] [Related]
3. Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of alphavbeta3 antagonists lead compounds.
Rockwell AL; Rafalski M; Pitts WJ; Batt DG; Petraitis JJ; DeGrado WF; Mousa S; Jadhav PK
Bioorg Med Chem Lett; 1999 Apr; 9(7):937-42. PubMed ID: 10230615
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of enantiopure pyrrolidine-derived peptidomimetics and oligo-beta-peptides via nucleophilic ring-opening of beta-lactams.
Macías A; Ramallal AM; Alonso E; del Pozo C; González J
J Org Chem; 2006 Sep; 71(20):7721-30. PubMed ID: 16995679
[TBL] [Abstract][Full Text] [Related]
6. Concerted synthesis of a spirobicyclic type-VI beta-turn mimic of Pro-Pro-Pro-NH2.
Vartak AP; Johnson RL
Org Lett; 2006 Mar; 8(5):983-6. PubMed ID: 16494490
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimetics.
Moitessier N; Dufour S; Chrétien F; Thiery JP; Maigret B; Chapleur Y
Bioorg Med Chem; 2001 Feb; 9(2):511-23. PubMed ID: 11249143
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological investigation of novel tricyclic benzodiazepinedione-based RGD analogues.
Addicks E; Mazitschek R; Giannis A
Chembiochem; 2002 Nov; 3(11):1078-88. PubMed ID: 12404633
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiaggregatory activity of RGD-peptidomimetics based on 4-oxo-4-(piperazine-1-yl)butyric acid as Arg-mimetic.
Andronati SA; Krysko AA; Kabanov VM; Kabanova TA; Karaseva TL; Chugunov BM; Meshkova SB; Topilova ZM
Acta Pol Pharm; 2003; 60(5):375-81. PubMed ID: 15005421
[TBL] [Abstract][Full Text] [Related]
10. Optimized conventional synthesis of "RGD" and "RGDS" peptides and their sarcosine mimics as integrin GP IIb/IIIa antagonists.
Abo-Ghalia M; Abd El-Rahman S; El-Kafrawy A; Kalomuch A
Amino Acids; 2003 Jun; 24(4):405-11. PubMed ID: 12768503
[TBL] [Abstract][Full Text] [Related]
11. Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices.
Li LS; Rader C; Matsushita M; Das S; Barbas CF; Lerner RA; Sinha SC
J Med Chem; 2004 Nov; 47(23):5630-40. PubMed ID: 15509162
[TBL] [Abstract][Full Text] [Related]
12. Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
Del Gatto A; Zaccaro L; Grieco P; Novellino E; Zannetti A; Del Vecchio S; Iommelli F; Salvatore M; Pedone C; Saviano M
J Med Chem; 2006 Jun; 49(11):3416-20. PubMed ID: 16722662
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structural diversity-oriented peptidomimetics based on the cyclopropylic strain.
Mizuno A; Miura S; Watanabe M; Ito Y; Yamada S; Odagami T; Kogami Y; Arisawa M; Shuto S
Org Lett; 2013 Apr; 15(7):1686-9. PubMed ID: 23528142
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
[TBL] [Abstract][Full Text] [Related]
15. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of RGD peptidomimetics aimed at surface bioderivatization of polymer substrates.
Boxus T; Touillaux R; Dive G; Marchand-Brynaert J
Bioorg Med Chem; 1998 Sep; 6(9):1577-95. PubMed ID: 9801829
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of a cyclic RGD peptide that inhibits platelet aggregation.
Jois SD; Tambunan US; Chakrabarti S; Siahaan TJ
J Biomol Struct Dyn; 1996 Aug; 14(1):1-11. PubMed ID: 8877556
[TBL] [Abstract][Full Text] [Related]
18. Novel peptidomimetics of the antifungal cyclic peptide Rhodopeptin: design of mimetics utilizing scaffolding methodology.
Nakayama K; Kawato HC; Inagaki H; Ohta T
Org Lett; 2001 Nov; 3(22):3447-50. PubMed ID: 11678679
[TBL] [Abstract][Full Text] [Related]
19. Development of a new family of conformationally restricted peptides as potent nucleators of beta-turns. Design, synthesis, structure, and biological evaluation of a beta-lactam peptide analogue of melanostatin.
Palomo C; Aizpurua JM; Benito A; Miranda JI; Fratila RM; Matute C; Domercq M; Gago F; Martin-Santamaria S; Linden A
J Am Chem Soc; 2003 Dec; 125(52):16243-60. PubMed ID: 14692766
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the synthesis of some bioactive peptides and peptidomimetics.
Rajesh BM; Iqbal J
Curr Pharm Biotechnol; 2006 Aug; 7(4):247-59. PubMed ID: 16918402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
